— Know what they know.
Not Investment Advice
Also trades as: CLNNW (NASDAQ) · $vol 0M

CLNN NASDAQ

Clene Inc.
1W: -3.5% 1M: -0.2% 3M: -30.9% YTD: -28.1% 1Y: -40.5% 3Y: -60.7% 5Y: -97.1%
$4.08
+0.06 (+1.49%)
 
Weekly Expected Move ±14.7%
$3 $4 $4 $5 $5
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 42 · $52.1M mcap · 10M float · 1.02% daily turnover · Short 25% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
28.7 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: 132.5%
Cost Advantage
34
Intangibles
30
Switching Cost
18
Network Effect
39
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CLNN has No discernible competitive edge (28.7/100). The business operates without significant structural advantages. The primary source of advantage is Network Effects. ROIC of 132.5% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 7Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2022-05-02 Canaccord Genuity Sumant Kulkarni Initiated $10 — -31.7% $14.65

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
Oct 02, 2026
DCF
1
ROE
5
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CLNN receives an overall rating of C. Strongest factors: ROE (5/5). Areas of concern: DCF (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-03-12 D+ C
2026-03-12 C D+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 8 Grade D
Profitability
18
Balance Sheet
32
Earnings Quality
18
Growth
12
Value
23
Momentum
20
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CLNN scores highest in Balance Sheet (32/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-22.74
Distress Zone
Piotroski F-Score
2/9
✗ ✗ ✗ ✓ ✗ ✓ ✗ ✗ ✗
Beneish M-Score
-5.39
Unlikely Manipulator
Ohlson O-Score
7.01
Bankruptcy prob: 99.9%
High Risk
Credit Rating
B-
Score: 20.0/100
Trend: Stable
Earnings Quality
—
OCF/NI: 0.40x
Accruals: -104.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CLNN scores -22.74, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CLNN scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CLNN's score of -5.39 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CLNN's implied 99.9% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CLNN receives an estimated rating of B- (score: 20.0/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-1.15x
PEG
0.56x
P/S
264.65x
P/B
-2.04x
P/FCF
-4.78x
P/OCF
—
EV/EBITDA
-3.20x
EV/Revenue
451.53x
EV/EBIT
-3.04x
EV/FCF
-5.58x
Earnings Yield
-51.81%
FCF Yield
-20.91%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. CLNN currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.351
EBT / EBIT
×
EBIT Margin
-148.503
EBIT / Rev
×
Asset Turnover
0.009
Rev / Assets
×
Equity Multiplier
-1.355
Assets / Equity
=
ROE
237.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CLNN's ROE of 237.2% is driven by Asset Turnover (0.009), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$4.15
Median 1Y
$1.54
5th Pctile
$0.32
95th Pctile
$7.33
Ann. Volatility
94.9%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Robert Etherington
President and Chief Executive Officer
$508,763 $— $933,394
Mark Mortenson Science
cience Officer
$412,017 $— $809,426
Morgan R. Brown
Chief Financial Officer
$292,578 $— $487,650

CEO Pay Ratio

8:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $933,394
Avg Employee Cost (SGA/emp): $121,434
Employees: 76

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
76
+1.3% YoY
Revenue / Employee
$2,632
Rev: $200,000
Profit / Employee
$-344,382
NI: $-26,173,000
SGA / Employee
$121,434
Avg labor cost proxy
R&D / Employee
$184,355
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -61.4% -1.5% -97.8% -1.2% 13.5% -3.8% -145.3% -4.7% -6.7% -6.0% -37.0% -2.9% -4.2% -17.4% 82.0% 6.6% 3.7% 2.0% 2.8% 2.4% 2.37%
ROA -22.2% -14.8% 29.8% 26.3% -44.8% -55.6% -60.8% -87.1% -83.8% -1.0% -1.1% -56.3% -78.3% -98.9% -82.6% -95.1% -1.1% -1.2% -1.4% -1.7% -1.75%
ROIC 1.1% 2.9% 6.1% 463.7% -31.9% -3.3% -2.9% -8.5% -2.8% -3.0% -3.5% -2.6% -6.6% 154.7% -3.6% -4.2% -18.6% 16.3% 6.1% 1.3% 1.32%
ROCE -85.8% -84.1% -44.4% -58.6% -73.3% -86.9% -1.1% -72.5% -80.0% -1.7% -2.3% -2.1% -4.0% -2.1% -1.8% -1.8% -2.0% -3.2% -2.1% -1.6% -1.61%
Gross Margin 87.3% 3.6% 1.0% 1.0% 89.1% -77.4% 95.3% 75.5% 88.9% -1.7% 78.1% 80.2% 79.3% 80.2% 75.3% 1.0% 1.0% 70.1% -22.7% 60.0% 60.00%
Operating Margin -95.0% -70.6% -444.5% -388.4% -56.4% -49.9% -100.3% -38.4% -88.4% -58.4% -126.5% -81.2% -89.8% -95.1% -50.3% -217.2% -376.5% -94.1% -137.4% -59.4% -59.41%
Net Margin 263.1% 22.2% -445.1% -129.5% -63.1% -4.5% -110.0% -93.5% -22.4% -59.8% -151.8% -74.6% -91.8% -148.9% -9.3% -274.8% -585.1% -119.8% -539.4% -149.2% -149.16%
EBITDA Margin -87.5% 24.1% -412.6% -99.9% -56.8% 1.1% -96.3% -87.7% -7.3% -50.3% -129.0% -55.9% -75.4% -138.8% 3.2% -236.1% -517.5% -105.5% -463.0% -55.5% -55.49%
FCF Margin -57.2% -49.7% -75.2% -113.5% -102.9% -93.4% -72.1% -46.0% -45.5% -46.6% -45.3% -62.2% -56.3% -62.4% -55.0% -61.7% -86.9% -92.9% -135.1% -80.9% -80.95%
OCF Margin -55.7% -47.9% -71.4% -106.2% -93.4% -82.5% -63.9% -41.4% -42.8% -46.1% -45.2% -61.9% -56.1% -62.4% -55.0% -61.7% -86.9% -92.7% -134.8% -80.7% -80.75%
ROA 3Y Avg snapshot only -1.27%
ROIC Economic snapshot only 6.58%
Cash ROA snapshot only -69.04%
NOPAT Margin snapshot only -81.41%
Pretax Margin snapshot only -200.60%
R&D / Revenue snapshot only 65.06%
SGA / Revenue snapshot only 38.78%
SBC / Revenue snapshot only 27.51%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -35.74 -26.23 14.86 10.31 -7.28 -2.38 -3.03 -1.55 -1.58 -0.77 -1.12 -1.50 -0.84 -0.94 -0.93 -1.25 -2.03 -2.21 -1.71 -1.93 -1.149
P/S Ratio 865.03 353.35 458.59 426.75 405.99 150.35 156.25 96.59 88.70 58.34 88.14 103.47 71.50 107.97 77.66 130.20 289.80 289.36 428.40 387.20 264.647
P/B Ratio 84.13 20.28 122.78 -283.49 -19.08 21.97 -52.82 3.52 2.98 2.85 12.82 -90.74 -7.30 -4.17 -5.47 -4.36 -5.02 -3.29 -3.05 -3.08 -2.039
P/FCF -15.14 -7.11 -6.10 -3.76 -3.95 -1.61 -2.17 -2.10 -1.95 -1.25 -1.94 -1.66 -1.27 -1.73 -1.41 -2.11 -3.33 -3.11 -3.17 -4.78 -4.783
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -7.68 -4.88 -11.65 -7.73 -8.99 -3.12 -4.26 -1.34 -1.57 -0.82 -1.40 -2.40 -1.29 -1.35 -1.59 -2.01 -2.84 -3.38 -2.52 -3.20 -3.197
EV/Revenue 798.54 317.05 438.78 427.95 430.14 168.34 181.55 74.17 75.33 54.00 95.44 129.62 91.06 133.38 109.40 177.62 352.35 371.78 548.62 451.53 451.525
EV/EBIT -7.55 -4.78 -11.15 -7.40 -8.61 -2.99 -4.03 -1.29 -1.50 -0.79 -1.34 -2.24 -1.23 -1.29 -1.49 -1.89 -2.69 -3.17 -2.40 -3.04 -3.041
EV/FCF -13.97 -6.38 -5.83 -3.77 -4.18 -1.80 -2.52 -1.61 -1.65 -1.16 -2.11 -2.09 -1.62 -2.14 -1.99 -2.88 -4.05 -4.00 -4.06 -5.58 -5.578
Earnings Yield -2.8% -3.8% 6.7% 9.7% -13.7% -42.1% -33.0% -64.6% -63.4% -1.3% -89.3% -66.6% -1.2% -1.1% -1.1% -79.8% -49.2% -45.2% -58.4% -51.8% -51.81%
FCF Yield -6.6% -14.1% -16.4% -26.6% -25.3% -62.1% -46.2% -47.6% -51.3% -79.9% -51.4% -60.1% -78.7% -57.8% -70.9% -47.4% -30.0% -32.1% -31.5% -20.9% -20.91%
PEG Ratio snapshot only 0.561
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 13.54 9.06 7.77 4.13 3.49 2.11 1.47 9.31 3.04 1.53 1.23 0.99 0.83 1.57 1.36 1.58 1.53 0.83 1.94 3.07 3.074
Quick Ratio 13.53 9.05 7.76 4.11 3.49 2.10 1.47 9.30 3.04 1.53 1.22 0.99 0.82 1.56 1.36 1.57 1.52 0.83 1.93 3.07 3.066
Debt/Equity 4.18 1.91 12.80 -47.49 -2.88 9.83 -19.89 1.47 1.52 2.40 7.61 -65.96 -5.55 -2.35 -4.21 -2.44 -1.72 -1.23 -1.17 -0.90 -0.902
Net Debt/Equity -6.47 -2.08 -5.30 — — 2.63 — -0.82 -0.45 -0.21 1.06 — — — — — — — — — —
Debt/Assets 0.33 0.38 0.48 0.60 0.74 0.72 0.81 0.47 0.54 0.61 0.72 0.82 0.72 0.76 0.83 0.94 0.96 1.20 1.02 0.97 0.970
Debt/EBITDA -0.41 -0.51 -1.27 -1.29 -1.28 -1.25 -1.38 -0.73 -0.94 -0.74 -0.77 -1.39 -0.77 -0.62 -0.87 -0.82 -0.80 -0.99 -0.76 -0.80 -0.803
Net Debt/EBITDA 0.64 0.56 0.53 -0.02 -0.50 -0.33 -0.59 0.40 0.28 0.07 -0.11 -0.48 -0.28 -0.26 -0.46 -0.54 -0.51 -0.75 -0.55 -0.46 -0.456
Interest Coverage -63.65 -50.48 -17.99 -11.35 -7.92 -8.08 -6.91 -11.44 -8.47 -9.86 -9.31 -5.20 -6.59 -8.69 -7.48 -9.52 -11.44 -8.76 -10.70 -10.15 -10.154
Equity Multiplier 12.85 5.01 26.46 -79.12 -3.86 13.75 -24.52 3.15 2.82 3.91 10.57 -80.02 -7.65 -3.09 -5.09 -2.59 -1.81 -1.03 -1.15 -0.93 -0.930
Cash Ratio snapshot only 1.993
Debt Service Coverage snapshot only -9.657
Cash to Debt snapshot only 0.433
FCF to Debt snapshot only -0.714
Defensive Interval snapshot only 197.3 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.009
Inventory Turnover 22.44 2.49 0.23 -6.36 -12.76 10.33 6.97 6.35 7.01 13.57 8.86 11.37 4.41 1.33 1.97 0.97 0.40 0.82 8.22 7.14 7.138
Receivables Turnover (trade) 16.26 20.66 0.53 0.34 4.52 3.97 0.56 0.68 7.56 3.94 9.76 0.64 2.03 3.30 0.44 0.23 0.48 6.25 0.06 0.29 0.289
Payables Turnover 0.98 0.19 0.02 -0.18 -0.23 0.18 0.22 0.19 0.19 0.24 0.49 0.53 0.29 0.05 0.05 0.06 0.02 0.04 0.28 0.42 0.420
DSO (trade) 22 18 689 1082 81 92 657 538 48 93 37 569 180 110 821 1618 768 58 6141 1262 1261.8 days
DIO 16 147 1559 — — 35 52 57 52 27 41 32 83 274 185 378 908 446 44 51 51.1 days
DPO 372 1924 16076 — — 2076 1630 1941 1958 1518 742 690 1271 7154 7542 6172 14634 9049 1314 868 868.4 days
Cash Conversion Cycle (trade) -333 -1760 -13827 — — -1949 -921 -1346 -1858 -1399 -664 -89 -1009 -6770 -6535 -4176 -12958 -8545 4871 444 444.5 days
Fixed Asset Turnover snapshot only 0.024
Operating Cycle snapshot only 1312.9 days
Cash Velocity snapshot only 0.020
Capital Intensity snapshot only 116.959
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 2.1% 2.5% 54.7% -30.9% -20.8% -34.6% 1.9% 1.1% 63.9% 38.3% 12.7% -43.6% -41.4% -47.7% -43.5% -35.3% -49.2% -41.5% -61.7% -31.1% -31.12%
Net Income 33.9% 49.5% 1.3% 1.3% -82.6% -2.1% -2.7% -4.2% -65.2% -65.5% -72.3% 37.8% 10.8% 20.4% 40.4% 2.5% 15.3% 33.6% -15.3% -33.0% -33.03%
EPS 34.5% 41.8% 1.3% 1.3% -1.0% -1.7% -2.4% -3.3% 18.3% 8.6% -2.0% 58.3% 12.7% 26.4% 56.7% 34.2% 46.0% 53.1% 12.6% -2.3% -2.32%
FCF -88.2% -86.1% -59.9% -33.3% -42.5% -22.9% 2.3% 15.1% 27.4% 31.0% 29.2% 23.7% 27.6% 30.0% 31.5% 35.8% 21.5% 12.9% 6.0% 9.6% 9.62%
EBITDA -2.1% -92.3% 66.0% 64.0% 63.5% 45.7% -15.2% -1.1% -64.3% -69.6% -80.8% 45.2% 14.0% 22.1% 43.3% -6.1% 10.5% 34.7% -21.6% -10.0% -9.97%
Op. Income -1.9% -1.5% -85.0% -38.6% -21.3% 3.1% 11.3% 17.3% 16.8% 16.3% 14.8% 15.2% 18.7% 18.4% 28.4% 26.8% 29.5% 31.0% 25.5% 23.1% 23.14%
OCF Growth snapshot only 9.84%
Asset Growth snapshot only 4.14%
Debt Growth snapshot only 7.19%
Shares Change snapshot only 30.02%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — — — — — — 98.8% 1.1% 59.5% 47.0% 21.1% -6.5% -8.7% -22.1% -13.5% -8.6% -21.2% -24.9% -37.5% -36.9% -36.90%
Revenue 5Y — — — — — — — — — — — — — — 38.0% 29.3% 3.9% -0.6% -17.4% -18.3% -18.29%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — 1.1% 1.4% 22.7% -7.7% -12.6% — — -14.4% -17.6% -36.1% -42.8% 59.1% — — —
Gross Profit 5Y — — — — — — — — — — — — — — 87.2% 61.4% 8.1% 2.2% — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y — — 4.2% -1.9% -8.6% 44.1% 38.9% 72.7% 8.5% -8.5% -8.3% -18.1% -24.4% -24.3% -22.0% -20.8% -14.7% -25.9% -18.4% -30.2% -30.23%
Assets 5Y — — — — — — — — — — -0.9% -3.1% -7.7% 12.9% 11.2% 10.9% -14.0% -23.3% -18.0% -20.7% -20.66%
Equity 3Y — — -26.1% — — -12.8% — 1.8% -17.4% 2.4% — — — — — — — — — — —
Book Value 3Y — — -26.3% — — -13.5% — 1.6% -32.7% 1.8% — — — — — — — — — — —
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.96 0.94 0.96 0.65 0.76 0.63 0.88 0.72 0.73 0.37 0.92 0.50 0.49 0.23 0.34 0.16 0.03 0.00 0.15 0.52 0.523
Earnings Stability 0.03 0.06 0.01 0.02 0.45 0.39 0.01 0.08 0.71 0.69 0.15 0.10 0.77 0.70 0.05 0.03 0.51 0.29 0.01 0.01 0.013
Margin Stability — — 0.12 0.00 0.00 0.28 0.11 0.00 0.00 0.21 0.03 0.00 0.00 0.17 0.12 0.00 0.00 0.31 0.00 0.00 0.000
Rev. Growth Consistency 1.00 1.00 1.00 0.00 0.00 0.00 1.00 0.50 0.50 0.50 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.86 0.80 0.20 0.20 0.50 0.50 0.20 0.20 0.50 0.50 0.50 0.50 0.96 0.92 0.84 0.99 0.94 0.87 0.94 0.87 0.868
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend -0.90 28.73 — — — 19.41 — — — 1.31 — — — — — — — — — — —
Gross Margin Trend — — 0.69 2.47 2.06 -0.56 -0.40 -0.58 -0.53 -0.17 -0.45 -1.50 -1.44 0.67 0.63 0.70 0.78 0.30 -2.27 -1.43 -1.431
FCF Margin Trend — — 55.56 -8.28 -26.85 -21.68 1.88 40.25 34.46 24.94 28.34 17.59 17.93 7.63 3.69 -7.64 -36.04 -38.41 -84.92 -19.02 -19.022
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — 42.4% 35.6% — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 2.30 3.55 -2.31 -2.57 1.67 1.30 1.24 0.66 0.76 0.61 0.57 0.90 0.66 0.54 0.66 0.59 0.61 0.71 0.54 0.40 0.403
FCF/OCF 1.03 1.04 1.05 1.07 1.10 1.13 1.13 1.11 1.06 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.003
FCF/Net Income snapshot only 0.404
CapEx/Revenue 1.4% 1.8% 3.8% 7.3% 9.5% 10.9% 8.2% 4.6% 2.8% 50.5% 10.2% 23.5% 13.5% 4.4% 1.1% 0.7% 5.6% 19.5% 29.1% 20.3% 20.30%
CapEx/Depreciation snapshot only 0.028
Accruals Ratio 0.29 0.38 0.99 0.94 0.30 0.17 0.15 -0.29 -0.20 -0.40 -0.49 -0.06 -0.27 -0.45 -0.28 -0.39 -0.44 -0.34 -0.66 -1.05 -1.046
Sloan Accruals snapshot only 0.187
Cash Flow Adequacy snapshot only -397.675
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — 0.0% 0.0% — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — 0.0% 0.0% — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% -0.1% -16.1% -18.3% -70.7% -83.9% -1.1% -69.2% -0.0% -6.8% -25.0% -43.8% -38.2% -24.9% -0.0% -4.6% -8.9% -8.88%
Total Shareholder Return 0.0% 0.0% 0.0% 0.0% -0.1% -16.1% -18.3% -70.7% -83.9% -1.1% -69.2% -0.0% -6.8% -25.0% -43.8% -38.2% -24.9% -0.0% -4.6% -8.9% -8.88%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.01 0.96 1.02 1.02 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 0.23 0.21 -0.77 -0.70 1.13 1.12 1.14 1.09 1.12 1.10 1.11 1.19 1.15 1.12 1.13 1.11 1.09 1.11 1.09 1.35 1.351
EBIT Margin -105.77 -66.32 -39.35 -57.84 -49.98 -56.28 -45.01 -57.41 -50.31 -68.72 -71.09 -57.79 -74.29 -103.32 -73.27 -93.99 -131.05 -117.45 -228.72 -148.50 -148.503
Asset Turnover 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.009
Equity Multiplier 2.76 10.15 -3.29 -4.45 -30.01 6.79 239.10 5.36 7.98 5.82 32.22 5.14 5.32 17.58 -99.27 -6.90 -3.27 -1.72 -1.98 -1.36 -1.355
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-3.82 $-3.13 $5.30 $4.89 $-7.70 $-8.41 $-7.45 $-11.38 $-6.29 $-7.69 $-7.60 $-4.74 $-5.49 $-5.67 $-3.29 $-3.12 $-2.97 $-2.65 $-2.88 $-3.19 $-3.19
Book Value/Share $1.62 $4.04 $0.64 $-0.18 $-2.93 $0.91 $-0.43 $5.00 $3.33 $2.08 $0.66 $-0.08 $-0.63 $-1.27 $-0.56 $-0.90 $-1.20 $-1.78 $-1.62 $-2.00 $-2.00
Tangible Book/Share $1.62 $4.04 $0.64 $-0.18 $-2.93 $0.91 $-0.43 $5.00 $3.33 $2.08 $0.66 $-0.08 $-0.63 $-1.27 $-0.56 $-0.90 $-1.20 $-1.78 $-1.62 $-2.00 $-2.00
Revenue/Share $0.16 $0.23 $0.17 $0.12 $0.14 $0.13 $0.14 $0.18 $0.11 $0.10 $0.10 $0.07 $0.06 $0.05 $0.04 $0.03 $0.02 $0.02 $0.01 $0.02 $0.02
FCF/Share $-9.03 $-11.54 $-12.92 $-13.41 $-14.19 $-12.43 $-10.43 $-8.37 $-5.09 $-4.74 $-4.38 $-4.28 $-3.61 $-3.07 $-2.18 $-1.85 $-1.81 $-1.89 $-1.55 $-1.29 $-1.29
OCF/Share $-8.80 $-11.11 $-12.27 $-12.54 $-12.88 $-10.97 $-9.24 $-7.54 $-4.78 $-4.69 $-4.37 $-4.26 $-3.60 $-3.07 $-2.18 $-1.85 $-1.81 $-1.88 $-1.55 $-1.28 $-1.29
Cash/Share $17.29 $16.14 $11.62 $8.30 $5.11 $6.56 $4.85 $11.45 $6.56 $5.44 $4.35 $3.38 $2.23 $1.75 $1.11 $0.76 $0.77 $0.53 $0.51 $0.78 $0.78
EBITDA/Share $-16.42 $-15.08 $-6.47 $-6.54 $-6.60 $-7.17 $-6.16 $-10.12 $-5.36 $-6.72 $-6.60 $-3.71 $-4.52 $-4.84 $-2.72 $-2.66 $-2.58 $-2.23 $-2.51 $-2.25 $-2.25
Debt/Share $6.79 $7.72 $8.22 $8.44 $8.44 $8.95 $8.51 $7.36 $5.06 $5.00 $5.05 $5.18 $3.49 $3.00 $2.37 $2.19 $2.07 $2.20 $1.89 $1.80 $1.80
Net Debt/Share $-10.50 $-8.42 $-3.40 $0.14 $3.33 $2.39 $3.66 $-4.09 $-1.50 $-0.44 $0.71 $1.80 $1.26 $1.25 $1.26 $1.42 $1.30 $1.67 $1.38 $1.02 $1.02
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -22.740
Altman Z-Prime snapshot only -50.657
Piotroski F-Score 3 5 4 3 3 0 1 4 3 3 3 3 1 3 3 3 4 2 2 2 2
Beneish M-Score -1.64 3.47 3.87 3.51 0.19 -3.93 0.30 1.73 -3.62 -5.13 -5.15 15.96 -4.98 -8.08 -4.17 -3.47 1.19 -5.35 3.11 -5.39 -5.390
Ohlson O-Score snapshot only 7.007
Net-Net WC snapshot only $-2.66
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only B-
Credit Score 22.12 24.77 21.57 20.00 20.00 21.22 20.00 27.97 27.10 21.79 17.79 17.76 17.73 20.00 20.00 20.00 20.00 17.16 20.00 20.00 20.000
Credit Grade snapshot only 16
Credit Trend snapshot only 0.000
Implied Spread (bps) snapshot only 900.000
Industry Credit Rank snapshot only 16
Sector Credit Rank snapshot only 17

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms